68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
NCT02162446
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroenteropancreatic Neuroendocrine Tumors
Interventions
DRUG:
satoreotide trizoxetan
Sponsor
Ipsen